- Home
- QD vs BNTC Comparison
QD vs BNTC Comparison
Compare QD & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QD
- BNTC
- Stock Information
- Founded
- QD 2014
- BNTC 1995
- Country
- QD China
- BNTC United States
- Employees
- QD N/A
- BNTC N/A
- Industry
- QD Finance: Consumer Services
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- QD Finance
- BNTC Health Care
- Exchange
- QD Nasdaq
- BNTC Nasdaq
- Market Cap
- QD 433.7M
- BNTC 366.6M
- IPO Year
- QD 2017
- BNTC N/A
- Fundamental
- Price
- QD $3.33
- BNTC $12.89
- Analyst Decision
- QD
- BNTC Strong Buy
- Analyst Count
- QD 0
- BNTC 6
- Target Price
- QD N/A
- BNTC $23.83
- AVG Volume (30 Days)
- QD 614.1K
- BNTC 234.8K
- Earning Date
- QD 09-05-2025
- BNTC 05-14-2025
- Dividend Yield
- QD N/A
- BNTC N/A
- EPS Growth
- QD N/A
- BNTC N/A
- EPS
- QD 0.24
- BNTC N/A
- Revenue
- QD $25,682,957.00
- BNTC N/A
- Revenue This Year
- QD N/A
- BNTC N/A
- Revenue Next Year
- QD N/A
- BNTC N/A
- P/E Ratio
- QD $14.14
- BNTC N/A
- Revenue Growth
- QD 16.24
- BNTC N/A
- 52 Week Low
- QD $1.64
- BNTC $7.05
- 52 Week High
- QD $3.50
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- QD 70.43
- BNTC 50.13
- Support Level
- QD $3.20
- BNTC $12.57
- Resistance Level
- QD $3.50
- BNTC $13.88
- Average True Range (ATR)
- QD 0.14
- BNTC 1.18
- MACD
- QD 0.04
- BNTC 0.02
- Stochastic Oscillator
- QD 79.67
- BNTC 62.63
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.